NOVEMBER 20–SENATOR GILLEBRAND AND COLLEAGUES DEMAN EXPLANATIONS WHY MEDICAID FRAUD INVESTIGATIONS ARE BEING COMPROMISED BY WASHINGTON

GILLIBRAND, COLLEAGUES DEMAND ANSWERS ON DR. OZ’S ACTIONS TO DISMANTLE MEDICAID FRAUD PREVENTION Washington, D.C. – U.S. Senator Kirsten Gillibrand (D-NY) joined five of her Senate colleagues to launch an inquiry into the Trump administration’s politically motivated campaign against state … Continue reading →

Posted in Uncategorized